Exane Derivatives’s Abbott ABT Stock Holding History

Exane Derivatives’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-939	Closed	-$111K	–	763
2022 Q1	$111K	Sell	939 -769	-45%	-$95.3K	0.03%	456
2021 Q4	$240K	Buy	1,708 +62	+4%	+$7.94K	0.06%	303
2021 Q3	$194K	Buy	1,646 +1,392	+548%	+$171K	0.05%	398
2021 Q2	$30.1K	Buy	+254	New	+$29.6K	0.01%	683
2021 Q1	–	Sell	-1,165	Closed	-$128K	–	882
2020 Q4	$128K	Sell	1,165 -1,941	-62%	-$211K	0.04%	360
2020 Q3	$338K	Sell	3,106 -46	-1%	-$4.67K	0.1%	168
2020 Q2	$288K	Buy	3,152 +2,202	+232%	+$199K	0.08%	191
2020 Q1	$75K	Sell	950 -192	-17%	-$16K	0.02%	319
2019 Q4	$99.8K	Sell	1,142 -94	-8%	-$7.87K	0.02%	315
2019 Q3	$103K	Buy	1,236 +86	+7%	+$7.31K	0.02%	316
2019 Q2	$96.7K	Buy	+1,150	New	+$90.5K	0.02%	333
2019 Q1	–	Sell	-586	Closed	-$42.4K	–	639
2018 Q4	$42.4K	Buy	+586	New	+$41.2K	0.01%	370
2017 Q1	–	Sell	-1	Closed	-$38	–	570
2016 Q4	$38	Hold	1	–	–	﹤0.01%	587
2016 Q3	$42	Hold	1	–	–	﹤0.01%	568
2016 Q2	$39	Hold	1	–	–	﹤0.01%	502
2016 Q1	$42	Buy	+1	New	+$40	﹤0.01%	556
2015 Q4	–	Sell	-1	Closed	-$40	–	503
2015 Q3	$40	Buy	+1	New	+$47	﹤0.01%	508
2015 Q2	–	Sell	-88	Closed	-$4.08K	–	523
2015 Q1	$4.08K	Sell	88 -724	-89%	-$33.2K	﹤0.01%	409
2014 Q4	$36.6K	Buy	+812	New	+$35.4K	0.01%	349

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Exane Derivatives's ABT Position: Q2 2022 in Review

Exane Derivatives sold out of Abbott (ABT) in Q2 2022, closing a stake of 939 shares — an estimated $111K sold.

Exane Derivatives first reported a position in ABT in Q4 2014 and held it in 19 quarters. The position peaked at $338K in Q3 2020. 2,697 funds tracked by Wall St. Rank hold ABT as of Q2 2022.

Exane Derivatives reported no remaining Abbott position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 939 Abbott shares in Q2 2022, an estimated $111K.
Exane Derivatives first reported a position in Abbott in Q4 2014 and held it in 19 quarters.
Exane Derivatives's Abbott position peaked at $338K in Q3 2020.
2,697 funds tracked by Wall St. Rank held Abbott as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.